{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:06:22Z","timestamp":1753877182197,"version":"3.41.2"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T00:00:00Z","timestamp":1608768000000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal malignancies of the gastrointestinal tract. GISTs can occur in the background of neurofibromatosis 1 (NF-1), where chemotherapeutic treatment is not optimal and surgical intervention is the only management option. In this case report, we present a case involving a 61-year-old gentleman with NF-1. The patient presented with acute blood loss anemia that was initially controlled with embolization of a hyper-vascular mass abutting the distal jejunum. The patient was taken to the operating room for excision of the mass. All macroscopic disease was excised and the pathology noted GISTs. Surgical decision making is not clearly delineated in the literature for GISTs in patients with NF-1, where targeted therapy is not a treatment option. Resection of all disease should be considered, since NF-1 associated GISTs generally do not have harbor mutations that can be targeted.<\/jats:p>","DOI":"10.1093\/jscr\/rjaa516","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T04:11:09Z","timestamp":1606363869000},"source":"Crossref","is-referenced-by-count":1,"title":["Case report: multiple gastrointestinal stroma tumors in the background of neurofibromatosis type 1"],"prefix":"10.1093","volume":"2020","author":[{"given":"Tim N","family":"Beck","sequence":"first","affiliation":[{"name":"Department of General Surgery, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Lapinski","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram K","family":"Gurajala","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasra","family":"Karamlou","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toms","family":"Augustin","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,12,24]]},"reference":[{"key":"2020122407093042000_ref1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/cncr.20862","article-title":"Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era\u2014a population-based study in western Sweden","volume":"103","author":"Nilsson","year":"2005","journal-title":"Cancer"},{"volume-title":"SEER Cancer Statistics Review, 1975-2017","author":"Howlader","key":"2020122407093042000_ref2"},{"key":"2020122407093042000_ref3","doi-asserted-by":"crossref","first-page":"e9097","DOI":"10.1097\/MD.0000000000009097","article-title":"Advanced gastrointestinal stromal tumor patients benefit from palliative surgery after tyrosine kinase inhibitors therapy","volume":"97","author":"Qiu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2020122407093042000_ref4","doi-asserted-by":"crossref","first-page":"e07780","DOI":"10.7554\/eLife.07780","article-title":"Loss of neurofibromin Ras-GAP activity enhances the formation of cardiac blood islands in murine embryos","volume":"4","author":"Yzaguirre","year":"2015","journal-title":"Elife"},{"key":"2020122407093042000_ref5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11864-015-0384-y","article-title":"The role of surgery in metastatic gastrointestinal stromal tumors","volume":"17","author":"Keung","year":"2016","journal-title":"Curr Treat Options Oncol"},{"key":"2020122407093042000_ref6","doi-asserted-by":"crossref","first-page":"22840","DOI":"10.1038\/srep22840","article-title":"Role of surgery in patients with focally progressive gastrointestinal stromal tumors resistant to imatinib","volume":"6","author":"Gao","year":"2016","journal-title":"Sci Rep"},{"key":"2020122407093042000_ref7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ctrv.2016.11.011","article-title":"GEIS guidelines for gastrointestinal sarcomas (GIST)","volume":"55","author":"Poveda","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"2020122407093042000_ref8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ejso.2013.12.020","article-title":"Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib\u2014analysis of prognostic factors (EORTC-STBSG collaborative study)","volume":"40","author":"Bauer","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"2020122407093042000_ref9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jso.23451","article-title":"Metastasectomy for gastrointestinal stromal tumors","volume":"109","author":"Bamboat","year":"2014","journal-title":"J Surg Oncol"},{"key":"2020122407093042000_ref10","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.0.CO;2-N","article-title":"Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population","volume":"79","author":"Zoller","year":"1997","journal-title":"Cancer"}],"container-title":["Journal of Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jscr\/article-pdf\/2020\/12\/rjaa516\/35099994\/rjaa516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jscr\/article-pdf\/2020\/12\/rjaa516\/35099994\/rjaa516.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T15:04:50Z","timestamp":1608822290000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jscr\/article\/doi\/10.1093\/jscr\/rjaa516\/6046273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jscr\/rjaa516","relation":{},"ISSN":["2042-8812"],"issn-type":[{"type":"electronic","value":"2042-8812"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,12,1]]},"article-number":"rjaa516"}}